Fusion Pharmaceuticals Inc. logo

Fusion Pharmaceuticals Inc.

NASDAQ:FUSN

Overview | Financials
Company Name Fusion Pharmaceuticals Inc.
Symbol FUSN
Currency USD
Price 21.55
Market Cap 1,833,043,000
Dividend Yield 0%
52-week-range 2.31 - 21.6
Industry Biotechnology
Sector Healthcare
CEO Dr. John F. Valliant Ph.D.
Website https://fusionpharma.com

An error occurred while fetching data.

About Fusion Pharmaceuticals Inc.

Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order to selectively deliver the alpha particle

Related Stocks

Beyond Air, Inc. logo

Beyond Air, Inc.

XAIR

0.419 USD

Profound Medical Corp. logo

Profound Medical Corp.

PROF

7.72 USD

Talkspace, Inc. logo

Talkspace, Inc.

TALK

1.96 USD

Rhythm Pharmaceuticals, Inc. logo

Rhythm Pharmaceuticals, Inc.

RYTM

49.62 USD

Aldeyra Therapeutics, Inc. logo

Aldeyra Therapeutics, Inc.

ALDX

6.03 USD

Mainz Biomed B.V. logo

Mainz Biomed B.V.

MYNZ

0.305 USD

XBiotech Inc. logo

XBiotech Inc.

XBIT

7.06 USD

CymaBay Therapeutics, Inc. logo

CymaBay Therapeutics, Inc.

CBAY

32.48 USD

Financials

Numbers are in millions USD

Numbers are in millions USD